Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liron Walsh

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantationBernd Krüger, Stefanie Krick, Navdeep Dhillon, et al.
JAMA|January 19, 2017
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical TrialsGeoffrey A Block, David A Bushinsky, John Cunningham, et al.
Kidney International Reports|October 8, 2021
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial DesignLiron Walsh, John F Reilly, Caitlin Cornwall, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2009
Tubular expression of KIM-1 does not predict delayed function after transplantationBernd Schröppel, Bernd Krüger, Liron Walsh, et al.
The New England Journal of Medicine|November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR CardiomyopathyMarianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Glomerular Diseases|October 30, 2023
Developing an Edema Clinician-Reported Outcome Measure for Nephrotic SyndromeDebbie S Gipson, Maisha Pal, Hailey Desmond, et al.
The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantationBernd Krüger, Stefanie Krick, Navdeep Dhillon, et al.
JAMA|January 19, 2017
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical TrialsGeoffrey A Block, David A Bushinsky, John Cunningham, et al.
Kidney International Reports|October 8, 2021
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial DesignLiron Walsh, John F Reilly, Caitlin Cornwall, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2009
Tubular expression of KIM-1 does not predict delayed function after transplantationBernd Schröppel, Bernd Krüger, Liron Walsh, et al.
The New England Journal of Medicine|November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR CardiomyopathyMarianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Glomerular Diseases|October 30, 2023
Developing an Edema Clinician-Reported Outcome Measure for Nephrotic SyndromeDebbie S Gipson, Maisha Pal, Hailey Desmond, et al.
The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.
Pageof 2